General
Migraine breakthrough: New drug halves attacks
 

Migraine breakthrough: New drug halves attacks

Shared by:

 
In a phase III clinical trial of people with episodic migraine, a drug called erenumab was found to cut the number of monthly migraine days by over half.
 
www.medicalnewstoday.com
 
1 Dec 2017 - General